Search Results - "Rossen, Philip Blach"

Health-Related Quality of Life in Long-Term Survivors of Testicular Cancer by Rossen, Philip Blach, Pedersen, Anette Fischer, Zachariae, Robert, von der Maase, Hans

“…A growing number of patients with testicular cancer (TC) become long-term survivors. As a consequence, quality-of-life (QOL) issues become increasingly…”
Get full text

The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor by Brinch, Charlotte Margareta, Hogdall, Estrid, Junker, Niels, Moeller, Holger Jon, Sandfeld-Paulsen, Birgitte, de Heer, Pieter, Penninga, Luit, Rossen, Philip Blach, Krarup-Hansen, Anders, Aggerholm-Pedersen, Ninna

“…This study investigates the prognostic value of plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) concentrations in patients with…”
Get full text

Hypercalcemia in metastatic GIST caused by systemic elevated calcitriol: a case report and review of the literature by Hygum, Katrine, Wulff, Christian Nielsen, Harsløf, Torben, Boysen, Anders Kindberg, Rossen, Philip Blach, Langdahl, Bente Lomholt, Safwat, Akmal Ahmed

“…Hypercalcemia is the most common oncologic metabolic emergency but very rarely observed in patients with gastrointestinal stromal tumour, which is a rare…”
Get full text

A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue Sarcomas by Vitfell-Rasmussen, Joanna, Judson, Ian, Safwat, Akmal, Jones, Robin L., Rossen, Philip Blach, Lind-Hansen, Maja, Knoblauch, Poul, Krarup-Hansen, Anders

“…Background. Belinostat is a novel histone deacetylase inhibitor. Primary Objectives. Maximum tolerated dose (MTD) and dose limiting toxicities (DLTs) of…”
Get full text

The Prognostic Value of Plasma Programmed Death Protein-1 in Patients with Gastrointestinal Stromal Tumor by Brinch, Charlotte Margareta, Hogdall, Estrid, Junker, Niels, Moeller, Holger Jon, Sandfeld-Paulsen, Birgitte, de Heer, Pieter, Penninga, Luit, Rossen, Philip Blach, Krarup-Hansen, Anders, Aggerholm-Pedersen, Ninna

“…No soluble biomarker is clinically implemented for patients with Gastrointestinal Stromal Tumor (GIST). High tissue expression of Programmed Death-Ligand 1…”
Get full text

A phase I/II clinical trial of belinostat by Safwat, Akmal, Jones, Robin L, Rossen, Philip Blach, Krarup-Hansen, Anders, Judson, Ian, Vitfell-Rasmussen, Joanna, Knoblauch, Poul, Lind-Hansen, Maja

“…Background. Belinostat is a novel histone deacetylase inhibitor. Primary Objectives. Maximum tolerated dose (MTD) and dose limiting toxicities (DLTs) of…”
Get full text